[email protected] 571.272.7822

Papel No. 18 Filed: September 25, 2015

UNITED STATES PATENT AND TRADEMARK OFFICE _____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ COALITION FOR AFFORDABLE DRUGS VI, LLC, Petitioner, v. CELGENE CORPORATION, Patent Owner. _______________ Case IPR2015-01092 (Patent 6,045,501) Case IPR2015-01096 (Patent 6,315,720) Case IPR2015-01102 (Patent 6,315,720) Case IPR2015-01103 (Patent 6,315,720) Case IPR2015-01169 (Patent 5,635,517)1 ____________ Before TONI R. SCHEINER, MICHAEL P. TIERNEY, MICHAEL W. KIM, JACQUELINE WRIGHT BONILLA, GRACE KARAFFA OBERMANN, and TINA E. HULSE, Administrative Patent Judges. TIERNEY, Administrative Patent Judge.

DECISION Denying Sanctions Motion 37 C.F.R. § 42.12 1

This Order addresses issues common to all identified cases. We exercise our discretion to issue one Order to be filed in each case. The parties are not authorized to use this style heading.

IPR2015-01092 (Patent 6,045,501) IPR2015-01096 (Patent 6,315,720) IPR2015-01102 (Patent 6,315,720) IPR2015-01103 (Patent 6,315,720) IPR2015-01169 (Patent 5,635,517) Patent Owner filed Motions for Sanctions (“Motion,” Paper 112) requesting dismissal of Petitioner’s Petitions in IPR2015-01092, -01096, -01102, -01103, and -01169. The Motion alleges that the Petitions represent an ongoing abuse of the inter partes review process that will be an unwarranted burden on the Board, and innovators like Patent Owner. Motion 1. According to the Motion, the Petitions are driven entirely by an admitted “profit motive” unrelated to the purpose of the American Invents Act,3 and unrelated to a competitive interest in the validity of the challenged patents. Id. at 2. Patent Owner requests dismissal of the Petitions on the basis that, even if the asserted validity challenges are “legitimate,” Petitioner’s reasons for seeking review are “illegitimate.” Id. at 11 (quoting Neumann v. Vidal, 710 F.2d 856, 860 (D.C. Cir. 1983)). Petitioner opposes the Motion. Opposition, Paper 12. Patent Owner filed a Reply. Paper 16. Patent Owner, as moving party, bears the burden of proof that it is entitled to the requested relief. 37 C.F.R. § 42.1(d). The default evidentiary standard for a motion is a preponderance of the evidence. 37 C.F.R. § 42.1(d). As the present Motion fails under the preponderance standard, we need not address whether a higher evidentiary standard applies.

2

Citations to papers and exhibits refer to those filed in IPR2015-01092. Similar papers and exhibits were filed in each of the other cases. 3 Leahy-Smith America Invents Act, Pub. L. No. 112-29, 125 Stat. 284 (2011) (“AIA”) 2

IPR2015-01092 (Patent 6,045,501) IPR2015-01096 (Patent 6,315,720) IPR2015-01102 (Patent 6,315,720) IPR2015-01103 (Patent 6,315,720) IPR2015-01169 (Patent 5,635,517) Profit Motive Patent Owner contends that Petitioner’s purported altruistic motive of lowering drug prices for consumers is a pretext. Motion 5–6. Patent Owner states that Petitioner seeks to profit from its Petitions for inter partes review. Id. at 5–7. Patent Owner contends that if the Board permits this strategy to continue, it will be inundated with similar petitions, and no public company that relies on patents will be safe from unnecessary petitions from for-profit organizations misusing inter partes reviews as investment strategies. Id. at 7. Profit is at the heart of nearly every patent and nearly every inter partes review. As such, an economic motive for challenging a patent claim does not itself raise abuse of process issues. We take no position on the merits of short-selling as an investment strategy other than it is legal, and regulated.

Lack of Competitive Interest Patent Owner contends that Petitioner has no competitive interest in the patents they challenge or the technology covered by the patents. Motion 6. Patent Owner states that the motivation for profit, combined with a lack of a competitive interest, is contrary to the America Invents Act’s purpose and represents an improper use of the proceeding. Id. at 13. The Leahy-Smith America Invents Act allows a person who is not the owner of a patent to file a petition with the Office to institute an inter partes review of the patent. 35 U.S.C. § 311. This is in contrast to covered 3

IPR2015-01092 (Patent 6,045,501) IPR2015-01096 (Patent 6,315,720) IPR2015-01102 (Patent 6,315,720) IPR2015-01103 (Patent 6,315,720) IPR2015-01169 (Patent 5,635,517) business method reviews, which require a party or privy to have been sued or charged with infringement of the patent. AIA, § 18(a)(1)(B). Accordingly, consistent with the proposition that Article III standing is not a requirement to appear before this administrative agency, we hold that Congress did not limit inter partes reviews to parties having a specific competitive interest in the technology covered by the patents. See Sierra Club v. E.P.A., 292 F.3d 895, 899 (D.C. Cir. 2002) (stating that an administrative agency is not subject to Article III of the Constitution of the United States, so a petitioner would have no need to establish standing to participate in proceedings before the agency); see also Consumer Watchdog v. Wis. Alumni Res. Found., 753 F.3d 1258, 1261 (Fed. Cir. 2014) (citing Sierra Club).

Purpose of America Invents Act Patent Owner states that the Petitions in these cases are contrary to the America Invents Act, as Congress intended inter partes reviews to allow parties to challenge a granted patent as an expeditious and less costly alternative to litigation. Motion 7. The purpose of the AIA was not limited to just providing a less costly alternative to litigation. Rather, the AIA sought to establish a more efficient and streamlined patent system that improved patent quality, while at the same time limiting unnecessary and counterproductive litigation costs. The AIA was designed to encourage the filing of meritorious patentability challenges, by any person who is not the patent owner, in an effort to further improve patent quality. H.R. Rep. No. 4

IPR2015-01092 (Patent 6,045,501) IPR2015-01096 (Patent 6,315,720) IPR2015-01102 (Patent 6,315,720) IPR2015-01103 (Patent 6,315,720) IPR2015-01169 (Patent 5,635,517) 112-98, pt. 1, at 85 (2011). In the Motion, Patent Owner does not allege that Petitioner filed a non-meritorious patentability challenge. Motion 10–12.

III.

Order In consideration of the foregoing, it is hereby ORDERED that Patent Owner’s Motions for Sanctions are denied.

PETITIONER: Sarah Spires [email protected] Parvathi Kota [email protected]

PATENT OWNER: Francis Cerrito [email protected] Anthony Insogna [email protected] lb

5

September 25, 2015 UNITED STATES PATENT ... - IPWatchdog.com

Sep 25, 2015 - and unrelated to a competitive interest in the validity of the challenged patents. Id. at 2. Patent Owner requests dismissal of the Petitions on the.

94KB Sizes 0 Downloads 162 Views

Recommend Documents

September 25, 2015 UNITED STATES PATENT ... - IPWatchdog.com
Sep 25, 2015 - the patents they challenge or the technology covered by the patents. ... business method reviews, which require a party or privy to have been ...

United States Patent
Jun 10, 1999 - Sep. 3, 2002. (54) INK JET INK COMPOSITION. W0. WO 00/27935. 5/2000. (75) Inventors: Wan Kang Zou; Xiaomang Wang,. OTHER PUBLICATIONS. (73). (*). (21) .... (List continued on next page.) Primary Examiner—Helene Klemanski. Assistant E

United States Patent [19]
Feb 11, 1977 - 1,417,421 12/1975 United Kingdom. Primary Examiner-Ellis Robinson. Attorney. Agent, or .... The melamine/formaldehyde resin syrups useful herein are well known to those skilled in the art. They ... well known in the art and contain fro

United States Patent 0
alcohol and washed several times with 60% alcohol, two of the washes containing 2% acetic acid and a subse quent wash containing just enough aqueous ammonia to render the alcohol neutral to B.D.H. Universal Indi cator. The ?nal wash was made with 60%

(12) United States Patent
Nov 28, 2001 - processing the image according to the type. The portable document format document includes a. knoWn context sensitive hierarchical structure. The context sensitive hierarchical structure, including the anchorable information unit, is s

United States Patent [191
Aug 23, 1979 - electrode of the cell, rendering the cell inoperative. In order to convert solar energy to electrical energy on a large scale, square miles of solar ...

United States Patent [19]
31 May 1996 - Attorney, Agent, or Firm—Cushman Darby & Cushman IP. Group of Pillsbury Madison & Sutro LLP. [57]. ABSTRACT. Pharmaceutically active derivatives ... replacement of the ambient atmosphere have not been found to be satisfactory as a mea

United States Patent [191
Aug 23, 1979 - subsequent to Apr. 25, 1995, has been disclaimed. [2]] App]. No. ... prior application for U.S. patent, Ser. No. .... scanning electron microscope.

(12) United States Patent
Oct 21, 2003 - Currency Systems International, CPS 1200; 4 pages; copyr. 1992. Glory GSA—500 Sortrnaster brochure; 2 pages; estirnated. Jan. 14, 1994. Sale of Glory GSA—500 Sortrnaster, 1986. Glory GFB—500/520, Desk—Top Bank Note Counters; 2

United States Patent [191
Jul 19, 1974 - sium stearate, stearic acid, talc, corn starch, lactone or the like. If desired, these tablets may be coated with sugar or shellac preparations in ...

United States Patent
Notice: This patent is subject to a terminal dis claimer. Appl. No.: 09/146,204. Filed: Sep. 2, 1998. Related US. ... 5,697,440 12/1997 Weaver et a1. .. 166/281. 5,791,415 8/1998 Nguyen et a1. . 166/280 ... packed With gravel, formation sand Will lik

United States Patent 0
pound in an aqueous medium at temperatures above about. 70° C. The compound ..... of. record in the patented ?le of this patent or the original patent. UNITED ...

United States Patent [191
{54] APPLE TREE-GOLDENSHEEN #2 ... sheen apple tree (French Brevet D'Invention 70.47735) ... chards Company at Louisiana, Pike County, Mo. .... Best. C0re.—Median. Bundle area (longitudinal section). —— Medium small; cordate ...

United States Patent 0 ”
vention, it is my belief that water insensitivity results from the desolubilization ..... molecular weight ethoxylines will be less e?icient cross ... In this connection, qua ..... line parts emulsion, Before. After. Alter parts water. 24-hr. (JG-hr.

United States Patent [19]
v.d.R] with deep red [13. deep R] background and slight moderate orange yellow [71. m.OY] freckling near the apex. Flesh: C0l0r—Light orange yellow [70. l.

United States Plant Patent
and the same cycle was done: in this population one plant was selected and .... Seed development: Seed development has not been observed. Pubescent.

United States Plant Patent
Jun 16, 2008 - (21) Appl NO . 12/214 214 ?owering habit; dark pink and white bi-colored ?owers; and ... of ordinary dictionary signi?cance are used. Botanical ...

United States Patent [19]
Related U'S' Apphcanon Data at Perry, Ohio. More particularly, the .... Cultivar Identi?cation With Scanning Electron Micros copy, a method developed by the ...

United States Plant Patent
Mar 30, 2010 - See application ?le for complete search history. (75) Inventor: Ushio .... to The Royal Horticultural Society Colour Chart, 2001 Edi tion, except ...

United States Plant Patent
Oct 28, 2008 - Pnor PUbhcatlon Data ing quality and an ... Foreign Application Priority Data y g .... spaced of 4.0 meters and trees spaced of 1 meter in a same.

(12) United States Plant Patent
May 16, 2008 - Use: Marketi local and long distance. Keeping quality: Good, Will store for 1 year With no break. doWn of kernel in appearance or ?avor.

United States Patent n91
protection circuits to said contacts of said ... number of protected places such as factories, banks ... conductive paths, usually ordinary telephone lines leased for ...

(12) United States Plant Patent
Aug 1, 2011 - cited by examiner. Primary Examiner * Howard Locker. (57). ABSTRACT. A new and distinct hybrid mesquite tree, Prosopis 'Leslie. Roy', which ...

United States Plant Patent
GroWth rate: Fast. Branching characteristics: Basal-branching. Length of primary lateral branches: 13 cm. Quantity of primary lateral branches: 10 to 12. ... Length .iAbout 2.0 cm. Width .iAbout 2 cm. Shape.4Obcordate. Apex.iRetuse. BaseiAcute. Margi